Status:

COMPLETED

Study to Evaluate Performance, Usability, Safety of Microwave Technology When Collecting Data From Patients With Stroke

Lead Sponsor:

Medfield Diagnostics

Conditions:

Stroke

Healthy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a prospective, open, multicenter study that will enroll patients admitted to and hospitalized at the Stroke Unit due to diagnosed stroke and healthy volunteers. The main purpose of the study ...

Detailed Description

After written informed consent has been acquired a physical examination will be performed followed by confirmation of the inclusion/exclusion criteria. After subject enrollment the microwave measureme...

Eligibility Criteria

Inclusion

  • (Group A)
  • Signed Informed Consent Form
  • Patient diagnosed (by CT) with ischemic stroke, within 24 hours of stroke onset
  • Patient should be ≥ 18 years of age
  • (Group B)
  • Signed Informed Consent Form
  • Patient diagnosed (by CT) with hemorrhagic stroke, within 48 hours of stroke onset
  • Patient should be ≥ 18 years of age
  • (Group C)
  • Signed Informed Consent Form
  • Subject should be ≥ 18 years of age

Exclusion

  • (Group A+B)
  • Pregnant or nursing woman
  • Woman of child bearing potential and not taking adequate contraceptive precautions
  • Patient that has already received thrombolytic treatment
  • Patient participating in any other clinical study that could interfere with the result in the present study
  • Patient diagnosed with a condition associated with risk of poor protocol compliance
  • Any other condition or symptoms preventing the patient from entering the study, according to the investigator´s judgment
  • Any patient that according to the Declaration of Helsinki is deemed unsuitable for study enrollment
  • (Group C)
  • Pregnant or nursing woman
  • Woman of child bearing potential and not taking adequate contraceptive precautions
  • Subject participating in any other clinical study that could interfere with the result in the present study
  • Any other condition or symptoms preventing the subject from entering the study, according to the investigator´s judgment
  • Any subject that according to the Declaration of Helsinki is deemed unsuitable for study enrolment

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

165 Patients enrolled

Trial Details

Trial ID

NCT02266459

Start Date

October 1 2014

End Date

July 1 2015

Last Update

August 11 2015

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Strokeenheten, Södra Älvsborgs Sjukhus

Borås, Borås, Sweden, 501 82

2

Sahlgrenska University Hospital/Sahlgrenska, Dept. of Neurology

Gothenburg, Göteborg, Sweden, 41345

3

Strokeenheten, Skaraborgs Sjukhus

Skövde, Sweden, 541 42